TITLE

Minimal invasive mitral valve repair for mitral regurgitation: results of 1339 consecutive patients

AUTHOR(S)
Seeburger, Joerg; Borger, Michael Andrew; Falk, Volkmar; Kuntze, Thomas; Czesla, Markus; Walther, Thomas; Doll, Nicolas; Mohr, Friedrich Wilhelm
PUB. DATE
October 2008
SOURCE
European Journal of Cardio-Thoracic Surgery;Oct2008, Vol. 34 Issue 4, p760
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Abstract: Objective: Some have expressed concern that minimal invasive mitral valve (MV) repair may not meet the standard of open surgical techniques. We therefore reviewed our results for minimal invasive MV repair for mitral regurgitation (MR). Material and methods: Between March 1999 and February 2007, a total of 1536 consecutive patients underwent minimal invasive MV surgery for MR at our institution using a right lateral mini-thoracotomy and femoral cannulation for cardiopulmonary bypass. Of these, a total of 1339 (87.2%) patients underwent MV repair and these form the focus of this study. The mean grade of preoperative MR was 3.3±0.6, age was 60.3±12.7 years, ejection fraction was 59.2±15.1% and 819 patients (61.2%) were male. Results: The procedure was successfully performed in all but four patients (0.3%) who required intraoperative conversion to full sternotomy. MV repair techniques consisted of ring annuloplasty with or without chordae-replacement or Carpentier-type leaflet resection. Concomitant procedures consisted of atrial fibrillation ablation in 351 patients (26.2%), tricuspid valve surgery in 80 patients (6.0%), and patent foramen ovale/atrial septal defect closure in 88 patients (6.6%). Mean duration of CPB was 121±38min and mean aortic cross-clamp time was 70±32min. Thirty-day mortality was 2.4%. Follow-up was performed in 99% of patients at an average of 28.1±23.9 months postoperatively. The Kaplan–Meier estimate for survival at 5 years was 82.6% (95% CI: 78.9–85.7%) and for freedom from MV reoperation was 96.3% (95% CI: 94.6–97.4%). Conclusions: Minimal invasive MV repair, along with certain concomitant procedures, can be performed in the vast majority of patients with MR. Our large series demonstrates that these procedures can be performed with low perioperative complication rates and very good durability.
ACCESSION #
34649554

 

Related Articles

  • Mid-term results of right axillary incision for the repair of a wide range of congenital cardiac defects. Dave, Hitendu Hasmukhlal; Comber, Maurice; Solinger, Theo; Bettex, Dominique; Dodge-Khatami, Ali; Prêtre, René // European Journal of Cardio-Thoracic Surgery;May2009, Vol. 35 Issue 5, p864 

    Abstract: Objective: We evaluated the mid-term results of the right axillary incision used for the repair of various congenital heart defects. Methods: All the patients who were operated with this incision between March 2001 and December 2007 were reviewed. There were 123 patients (median age...

  • Early and long-term outcomes of minimally invasive mitral valve surgery through right minithoracotomy: a 10-year experience in 1604 patients. Glauber, Mattia; Miceli, Antonio; Canarutto, Daniele; Lio, Antonio; Murzi, Michele; Gilmanov, Daniyar; Ferrarini, Matteo; Farneti, Pier A.; Quaini, Eugenio L.; Solinas, Marco // Journal of Cardiothoracic Surgery;12/7/2015, Vol. 10, p1 

    Background: To report early and long-term outcomes of patients undergoing minimally invasive mitral valve surgery (MIMVS) through right mini-thoracotomy (RT) over a 10-year period.Methods: From September 2003 to December 2013, a total of 1604 consecutive patients...

  • Nonbacterial thrombotic endocarditis as a surgical complication in a patient status post mitral valve repair with patent foramen ovale closure. Mihos, Christos G.; Artola, Rosa T.; Torres, Ana Maria // Internet Journal of Cardiology;2010, Vol. 9 Issue 1, p1 

    First described in the 1800s, nonbacterial thrombotic endocarditis (NBTE) was initially dismissed as clinically insignificant, a post-mortem diagnosis or complication seen in patients suffering from malignancies, hypercoagulable states or autoimmune disorders. While occasional studies and...

  • Attempting and aborting percutaneous closure of a peculiar atrial septal defect: important contribution of multiple real-time imaging modalities. João Abecasis; Raquel Dourado; Rui Ferreira; Ana Teixeira; Renata Rossi; Rui Anjos; Fernando Maymone // European Journal of Echocardiography;Mar2009, Vol. 10 Issue 2, p340 

    The case of a 19-year-old female with a neonatal diagnosis of Tetralogy of Fallot and complete atrioventricular (AV) septal defect is described. She had had a corrective surgery at the age of 6. She did well afterwards despite recent complain of fatigability with mild arterial hypoxaemia....

  • Intraoperative Device Closure of Atrial Septal Defects with Minimal Transthoracic Invasion. Peng Zhu; Yong Sun; Qian Yang; Feng Qiu // Texas Heart Institute Journal;2013, Vol. 40 Issue 3, p256 

    Atrial septal defect is one of the most common congenital heart defects. Open-heart repair via midline sternotomy or right thoracotomy and cardiopulmonary bypass has been considered the standard treatment for the closure of atrial septal defects, but transcatheter closure with the Amplatzer...

  • Thoracoscopic ASD closure is a reliable supplement for percutaneous treatment. Casselman, F. P.; Dom, H.; de Bruyne, B.; Vermeulen, Y.; Vonermen, H. // Heart;Jun2005, Vol. 91 Issue 6, p791 

    Objective: To determine the feasibility and effectiveness of endoscopic atrial septal defect (ASD) closure when percutaneous ASD closure is impossible or has failed. Patients: Between March 1997 and February 2003, 74 patients (63% female, mean (SD) age 44 (16) years) underwent an endoscopic ASD...

  • Do patients over 40 years of age benefit from closure of an atrial septal defect? Webb, G // Heart;Mar2001, Vol. 85 Issue 3, p249 

    An introduction is presented in which the editor discusses various reports within the issue on topics including the relationship between congenital heart disease and atrial septal defects (ASDs), coronary diseases, and mitral regurgitation.

  • Use of self-expanding venous cannula in tricuspid reoperation. Piñón, Miguel; Pradas, Gonzalo; Molina, Daniel; José Legarra, Juan // European Journal of Cardio-Thoracic Surgery;Sep2015, Vol. 48 Issue 3, p499 

    Significant tricuspid regurgitation requiring surgical correction is associated with poor survival in patients undergoing tricuspid valve reoperations. Right chamber dilatation increases the risk of injury during resternotomy. The novel technique of peripheral cannulation using an expandable...

  • Transventricular Mitral Valve Repair in Patients with Acute Forms of Ischemic Mitral Regurgitation. Cagli, Kerim; Selcuk Gedik, Hikmet; Korkmaz, Kemal; Budak, Baran; Yener, Umit; Lafci, Gokhan // Texas Heart Institute Journal;2014, Vol. 41 Issue 3, p312 

    The article describes the treatment of acute forms of ischemic mitral regurgitation using transventricular mitral valve (MV) repair. Topics covered include left ventricular (LV) restoration, papillary muscle imbrication, and cardiopulmonary bypass (CPB) via bicaval cannulation. Also mentioned...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics